Medidata Solutions, Inc. (NASDAQ:MDSO) CFO Rouven Bergmann sold 2,000 shares of the stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $65.40, for a total value of $130,800.00. Following the sale, the chief financial officer now directly owns 91,775 shares in the company, valued at $6,002,085. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Shares of Medidata Solutions, Inc. (NASDAQ MDSO) traded down $2.56 during trading hours on Monday, reaching $64.79. The company’s stock had a trading volume of 422,506 shares, compared to its average volume of 547,579. The stock has a market capitalization of $3,937.35, a PE ratio of 81.14, a price-to-earnings-growth ratio of 4.19 and a beta of 1.69. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.29 and a quick ratio of 3.37. Medidata Solutions, Inc. has a fifty-two week low of $47.77 and a fifty-two week high of $85.92.
Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Thursday, October 26th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.02. The business had revenue of $140.08 million for the quarter, compared to analysts’ expectations of $141.27 million. Medidata Solutions had a return on equity of 11.54% and a net margin of 7.84%. The business’s revenue for the quarter was up 16.7% on a year-over-year basis. During the same period last year, the firm posted $0.28 earnings per share. equities analysts forecast that Medidata Solutions, Inc. will post 0.77 earnings per share for the current year.
Several equities research analysts recently commented on MDSO shares. SunTrust Banks reaffirmed a “buy” rating and set a $92.00 price objective on shares of Medidata Solutions in a research report on Friday, October 27th. Dougherty & Co raised Medidata Solutions from a “neutral” rating to a “buy” rating and set a $75.00 price objective on the stock in a research report on Monday, November 13th. KeyCorp reaffirmed a “buy” rating and set a $86.00 price objective on shares of Medidata Solutions in a research report on Sunday, September 17th. Jefferies Group reaffirmed a “hold” rating and set a $78.00 price objective on shares of Medidata Solutions in a research report on Tuesday, August 22nd. Finally, Zacks Investment Research raised Medidata Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, September 20th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Medidata Solutions presently has a consensus rating of “Buy” and an average price target of $83.54.
A number of large investors have recently made changes to their positions in the business. California Public Employees Retirement System boosted its position in Medidata Solutions by 1.2% in the third quarter. California Public Employees Retirement System now owns 104,076 shares of the company’s stock worth $8,124,000 after purchasing an additional 1,276 shares during the last quarter. Zions Bancorporation purchased a new position in Medidata Solutions in the third quarter worth about $256,000. Jane Street Group LLC boosted its position in Medidata Solutions by 112.8% in the third quarter. Jane Street Group LLC now owns 9,505 shares of the company’s stock worth $742,000 after purchasing an additional 5,038 shares during the last quarter. AMP Capital Investors Ltd purchased a new position in Medidata Solutions in the third quarter worth about $2,194,000. Finally, Polen Capital Management LLC purchased a new position in Medidata Solutions in the third quarter worth about $205,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “Medidata Solutions, Inc. (MDSO) CFO Rouven Bergmann Sells 2,000 Shares” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/04/medidata-solutions-inc-mdso-cfo-rouven-bergmann-sells-2000-shares.html.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.